New Israeli-led AI model to predict chemotherapy benefit in breast cancer
Summary
Technion researchers part of international study that validates fast, accessible alternative to genomic tests using routine pathology samples.
Description
Technion researchers part of international study that validates fast, accessible alternative to genomic tests using routine pathology samples.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source